Requires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.*

Simple item page
dc.contributorCompiled by the New Jersey State Library
dc.date.accessioned2024-01-05T18:37:17Z
dc.date.available2024-01-05T18:37:17Z
dc.description.abstractYear: 2021, Chapter: 285
dc.identifier.urihttps://hdl.handle.net/10929.1/31763
dc.titleRequires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.*
dc.typeLegislative History
lg.NJSA30:4D-17.17a
lg.billNumberA277 Aca (1R)
lg.chapter285
lg.njlhidL2021c285
lg.synopsisRequires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.*
lg.titleRequires public members of Drug Utilization Review Board to disclose financial interests and benefits received from and investment interests held in pharmaceutical distributors, pharmaceutical manufacturers, or pharmacy benefits managers.*
lg.yearEnacted2021

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
L2021c285.pdf
Size:
1.29 MB
Format:
Adobe Portable Document Format
Download

Collections

2021